L57.3

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun Chronic sun damage over many years Genetic predisposition in some individuals Hormonal influences, especially in fair-skinned individuals Aging-related changes in skin elasticity and vascular structures Environmental factors such as pollution and skin irritants

Key Symptoms: Mottled pigmentation with a mixture of reddish and brownish patches primarily on the sides of the neck and upper chest Visible small blood vessels (telangiectasia) on the affected areas Skin thinning and increased fragility Possible mild itching or dryness Increased pigmentation in sun-exposed regions with a symmetrical pattern Absence of significant discomfort or pain

Diagnosis Path: Diagnosis of Poikiloderma of Civatte is primarily clinical, based on visual examination of the skin. A healthcare provider will assess the characteristic pattern of pigmentation, blood vessels, and skin thinning. In some cases, a skin biopsy may be performed to exclude other skin conditions and confirm the diagnosis. The doctor will also review the patient’s medical history, sun exposure habits, and any underlying health issues.

Treatment Protocols: While there is no cure for Poikiloderma of Civatte, several approaches can help improve the skin’s appearance and prevent progression: - **Sun protection**: Regular use of broad-spectrum sunscreens, wearing protective clothing, and avoiding excessive sun exposure - **Topical treatments**: Use of retinoids and bleaching agents may help reduce pigmentation - **Laser therapy**: Various laser and light-based treatments can diminish visible blood vessels and pigmentation - **Electrosurgery or phototherapy**: Methods to target abnormal blood vessels - **Cosmetic procedures**: Chemical peels or microdermabrasion to improve skin texture Patients are encouraged to discuss treatment options with a dermatologist to select the most suitable approach based on their skin type and severity of the condition.